Physician profile
Melissa Hurwitz
NPI 1124439849
$2,051.32
in general payments reported to CMS, 2019-2025
13 companies · $40.74 in 2025
The $40.74 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.74 · 2020: $88.16 · 2021: $16.29 · 2022: $1,646 · 2024: $248 · 2025: $40.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,244.00 | 2022 | |
| Medinc of Texas | $304.31 | 2022 | |
| Amgen INC. | $219.81 | 2024-2025 | Krystexxa |
| Stryker Corporation | $97.95 | 2022 | |
| Paragon 28, INC. | $40.18 | 2024 | Bun-Yo-Matic |
| Paratek Pharmaceuticals, INC. | $30.77 | 2020 | |
| Smith+Nephew, INC. | $24.19 | 2020 | |
| Amniox Medical, INC. | $19.35 | 2020 | |
| Horizon Therapeutics Plc | $16.29 | 2021 | |
| Bioventus LLC | $15.07 | 2024 | Exogen Ultrasound Bone Healing System |
| Celularity INC. | $13.85 | 2020 | |
| Mimedx Group, INC. | $13.81 | 2024 | |
| Merck Sharp & Dohme LLC | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Hurwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.